MULTIVERSE PHARMA Trademark

Trademark Overview


On Wednesday, October 7, 2020, a trademark application was filed for MULTIVERSE PHARMA with the United States Patent and Trademark Office. The USPTO has given the MULTIVERSE PHARMA trademark a serial number of 90239441. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Sunday, July 3, 2022. The MULTIVERSE PHARMA trademark is filed in the Pharmaceutical Products category with the following description:

Amino acids for medical purposes; Anti-cancer preparations; Medicines for Neurodegenerative Diseases and Cancer; Medical preparations for the treatment of Neurodegenerative Diseases and Cancer; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment and prevention of Neurodegenerative Diseases and Cancer; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Gene therapy products, namely, genetically engineered tissues for transplant purposes
multiverse pharma

General Information


Serial Number90239441
Word MarkMULTIVERSE PHARMA
Filing DateWednesday, October 7, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateSunday, July 3, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 20, 2021

Trademark Statements


Description of MarkThe mark consists of A shape comprised of three lines formed into three continuous horizontal loops above the word "MULTIVERSE" wherein the letter "V" is comprised of two lines, all of which is located above the word "PHARMA".
Goods and ServicesAmino acids for medical purposes; Anti-cancer preparations; Medicines for Neurodegenerative Diseases and Cancer; Medical preparations for the treatment of Neurodegenerative Diseases and Cancer; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment and prevention of Neurodegenerative Diseases and Cancer; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Gene therapy products, namely, genetically engineered tissues for transplant purposes
Disclaimer with Predetermined Text"PHARMA"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 23, 2020
Primary Code005
First Use Anywhere DateThursday, August 12, 2021
First Use In Commerce DateTuesday, October 12, 2021

Trademark Owner History


Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressPoway, CA 92064

Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressPoway, CA 92064

Trademark Events


Event DateEvent Description
Tuesday, July 5, 2022ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Sunday, July 3, 2022ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Sunday, July 3, 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Saturday, December 11, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, December 11, 2021NON-FINAL ACTION E-MAILED
Saturday, December 11, 2021SU - NON-FINAL ACTION - WRITTEN
Monday, November 29, 2021STATEMENT OF USE PROCESSING COMPLETE
Thursday, October 28, 2021USE AMENDMENT FILED
Wednesday, November 17, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 28, 2021TEAS STATEMENT OF USE RECEIVED
Tuesday, June 15, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 20, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 20, 2021PUBLISHED FOR OPPOSITION
Wednesday, March 31, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 15, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 12, 2021EXAMINER'S AMENDMENT ENTERED
Friday, March 12, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, March 12, 2021EXAMINERS AMENDMENT E-MAILED
Friday, March 12, 2021EXAMINERS AMENDMENT -WRITTEN
Monday, March 8, 2021ASSIGNED TO EXAMINER
Tuesday, November 24, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, November 23, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, October 10, 2020NEW APPLICATION ENTERED